Keyphrases
Adult Patients
25%
American Gastroenterological Association
12%
Assessment Approach
12%
Assessment Development
12%
Best Practice Statement
12%
Certainty of Evidence
12%
Clinical Practice Guidelines
100%
Course of Action
12%
Development Approach
12%
Evaluation Approach
12%
Evaluation Assessment
12%
Evidence to Decision Framework
12%
Grading of Recommendations
12%
Immune-mediated Inflammatory Diseases
12%
Immunization
100%
Immunogenicity
12%
Immunosuppressive Medication
37%
Immunosuppressive Therapy
87%
Inflammatory Bowel Disease
100%
Iterative Process
12%
Live Vaccine
100%
Measles-mumps-rubella Vaccine
12%
Multidisciplinary Panel
12%
Patient Outcomes
12%
Pediatric Patients
37%
Safety Self-efficacy
12%
Serious Adverse Events
12%
Strength of Recommendations
12%
Surrogate Outcomes
12%
Undesirable Effects
12%
Vaccination
25%
Vaccination Safety
12%
Vaccination Status
25%
Vaccine Effectiveness
50%
Vaccine Safety
12%
Vaccine-preventable Diseases
25%
Varicella Vaccine
25%
Working Diagnosis
12%
Nursing and Health Professions
Adverse Event
10%
Biological Product
10%
Disease
20%
Drug Therapy
30%
Immunosuppressive Agent
30%
Immunosuppressive Treatment
70%
Inflammatory Bowel Disease
10%
Inflammatory Disease
10%
MMR Vaccine
10%
Patient with Inflammatory Bowel Disease
100%
Pediatrics Patient
30%
Population
10%
Practice Guideline
100%
Systematic Review
10%
Treatment Outcome
10%
Vaccination Policy
50%
Vaccine Efficacy
100%
Varicella Vaccine
20%
Medicine and Dentistry
Adverse Event
14%
Biological Product
14%
Chickenpox Vaccine
28%
Disease
28%
Drug Therapy
42%
Immunogenicity
14%
Immunosuppressive Drug
42%
Immunosuppressive Treatment
100%
Inflammatory Bowel Disease
14%
Inflammatory Disorder
14%
Measles Mumps Rubella Vaccine
14%
Patient with Inflammatory Bowel Disease
100%
Pediatrics Patient
42%
Population
14%
Systematic Review
14%
Vaccine
14%
Immunology and Microbiology
Biological Product
10%
Immune-Mediated Inflammatory Diseases
10%
Immunogenicity
10%
Immunosuppressive Drug
30%
Immunosuppressive Therapy
70%
Inflammatory Bowel Disease
100%
MMR Vaccine
10%
Population
10%
Vaccination Policy
50%
Vaccine Efficacy
100%
Varicella Vaccine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
10%
Biological Product
10%
Chickenpox Vaccine
20%
Disease
20%
Immunogenicity
10%
Immunosuppressive Agent
100%
Inflammatory Bowel Disease
100%
Inflammatory Disease
10%
Measles Mumps Rubella Vaccine
10%
Vaccination Policy
50%
Vaccine
10%